Hyperbaric Oxygen Therapy Market Report 2026

The hyperbaric oxygen therapy market size has grown rapidly in recent years. It will grow from $4.9 billion in 2025 to $5.44 billion in 2026 at a compound annual growth rate (CAGR) of 11%. The growth in the historic period can be attributed to increasing incidence of chronic non-healing wounds, established use in decompression sickness treatment, rising cases of carbon monoxide poisoning, clinical validation in radiation injury management, hospital-based availability of hyperbaric chambers.

The hyperbaric oxygen therapy market size is expected to see strong growth in the next few years. It will grow to $7.89 billion in 2030 at a compound annual growth rate (CAGR) of 9.7%. The growth in the forecast period can be attributed to growing diabetic population with wound complications, technological advancements in chamber design, expanding outpatient and ambulatory use, rising awareness among healthcare providers, increasing reimbursement support in select regions. Major trends in the forecast period include expanding use of hbot in chronic wound management, growing adoption of portable and monoplace hbot systems, increasing clinical acceptance of hbot for radiation injuries, rising integration of hbot in multidisciplinary treatment protocols, expansion of hbot applications beyond traditional indications.

The rising prevalence of diabetes is expected to drive the growth of the hyperbaric oxygen therapy (HBOT) market in the coming years. Diabetes encompasses a group of chronic metabolic disorders characterized by prolonged high blood sugar levels. Its prevalence is increasing due to sedentary lifestyles, poor dietary habits, obesity, and genetic factors. HBOT is commonly used to manage diabetes-related complications, particularly diabetic foot ulcers and other non-healing wounds. For example, in June 2023, the Institute for Health Metrics and Evaluation, a US-based public health research institute, reported that over half a billion people worldwide were living with diabetes. This figure is projected to more than double to 1.3 billion by 2050. Consequently, the rising incidence of diabetes is fueling demand for hyperbaric oxygen therapy.

Key companies in the HBOT market are focusing on innovative products, such as advanced hyperbaric chambers, to enhance patient care. Hyperbaric chambers create a pressurized environment that allows patients to breathe pure oxygen, improving oxygen delivery to tissues and promoting healing. For instance, in January 2024, Sechrist Industries Inc., a US-based manufacturer of hyperbaric technology and medical equipment, launched the 3300 HM Hyperbaric Chamber. This chamber features an expansive interior to improve patient comfort and accessibility for a wide range of body sizes and mobility levels. Equipped with advanced monitoring systems, it allows real-time tracking of vital signs and chamber conditions, enhancing patient safety. Its state-of-the-art oxygen delivery system optimizes oxygen intake, while the user-friendly interface facilitates easy operation by healthcare professionals.

In July 2023, O2 Worx Ltd, a UK-based manufacturer of pressurized chambers for HBOT, partnered with SMP - Submarine Manufacturing & Products Ltd. The collaboration aims to expand the availability of hyperbaric oxygen chambers by combining O2 Worx’s health and wellness expertise with SMP’s established presence in the medical and diving equipment industry. The partnership will enable wider deployment of HBOT, enhanced training, and improved service in new markets. SMP is a UK-based company specializing in the manufacture and supply of commercial diving equipment.

Major companies operating in the hyperbaric oxygen therapy market are Healogics LLC, SOS Medical Group Ltd., Environmental Tectonics Corporation, Sechrist Industries Inc., BioBarica Profesionales, Perry Baromedical Corporation, Shanghai Baobang Medical Equipment Co. Ltd., Hyperbaric Modular Systems Inc., Baroks Hyperbaric, Haux-Life-Support GmbH, Haux-Technik GmbH, Hyperbaric SAC, Pan America Hyperbarics Inc., OxyHeal Health Group, Fink Engineering Pty Ltd, AHA Hyperbarics, The Oxybarica Group, NHC Medical And Beauty, Hyperbaric Medical Solutions, Gulf Coast Hyperbarics, Hearmec Co. Ltd., Hpotech Hyperbaric Solutions.

North America was the largest region in the hyperbaric oxygen therapy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hyperbaric oxygen therapy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the hyperbaric oxygen therapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs have impacted the hyperbaric oxygen therapy market by raising costs for imported pressure vessels, control systems, sensors, and medical-grade components used in HBOT chambers. These effects are most pronounced in advanced multiplace and customized systems, particularly in regions reliant on international manufacturing such as North America and Europe. At the same time, tariffs are encouraging local manufacturing, supplier diversification, and innovation in cost-efficient chamber designs, supporting long-term market resilience.

The hyperbaric oxygen therapy market research report is one of a series of new reports that provides hyperbaric oxygen therapy market statistics, including hyperbaric oxygen therapy industry global market size, regional shares, competitors with a hyperbaric oxygen therapy market share, detailed hyperbaric oxygen therapy market segments, market trends and opportunities, and any further data you may need to thrive in the hyperbaric oxygen therapy industry. This hyperbaric oxygen therapy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Hyperbaric oxygen therapy (HBOT) is a medical treatment in which patients breathe pure oxygen in a pressurized chamber or room. This therapy is used to manage a range of medical conditions, including decompression sickness (the bends), carbon monoxide poisoning, non-healing wounds, radiation injuries, and certain infections.

The main product types in the HBOT market include monoplace, multiplace, and topical hyperbaric oxygen therapy devices. Monoplace chambers are designed to accommodate a single patient, typically in a reclining position. HBOT is applied in various clinical scenarios such as wound healing, decompression sickness, gas embolism, infection management, and other conditions. These therapies are used by hospitals, clinics, ambulatory surgery centers, and other healthcare facilities.

The hyperbaric oxygen therapy market consists of sales of hyperbaric oxygen chambers, monitoring and cardiac support devices, oxygen delivery systems, medical gowns, and clear plastic tubes. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.